Status:
UNKNOWN
Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis
Lead Sponsor:
Wuhan University
Collaborating Sponsors:
NPO Organization to Support Peritoneal Dissemination Treatment
Kishiwada Tokushukai Hospital
Conditions:
Stomach Neoplasms
Colorectal Neoplasms
Eligibility:
All Genders
20-70 years
Phase:
PHASE2
Brief Summary
OBJECTIVES: * Determine response and survival of patients with peritoneal carcinomatosis treated with cytoreductive surgery plus intraoperative peritoneal hyperthermic chemotherapy with cisplatin and...
Detailed Description
DISEASE CHARACTERISTICS: * Histologically confirmed peritoneal carcinomatosis with the following histologies: * Primary peritoneal mesothelioma * Adenocarcinoma of gastrointestinal tract origin * Con...
Eligibility Criteria
Inclusion
- Gastric cancer or colorectal cancer with peritoneal carcinomatosis
- Gastric cancer or colorectal cancer with malignant ascites
- Karnofsky Performance Scale(KPS)\>50
Exclusion
- Age less than 20 years old, or beyond 70 years old
- Any lung metastasis, liver metastasis, or prominent retroperitoneal lymph node metastasis
- Bilirubin greater than 3 times upper limit of normal (ULN)
- AST and ALT greater than 5 times ULN
- Liver enzymes greater than 3 times ULN
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00454519
Start Date
March 1 2007
Last Update
February 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Center of Wuhan University & Department of Oncology, Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071